{"ORPHApacket":[{"ORPHApacketID":"411543","date":"2019-12-06 04:43:00","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"411543","Name":[{"lang":"en","label":"Severe phosphoribosylpyrophosphate synthetase superactivity"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_411543","DisorderType":[{"Name":[{"lang":"en","label":"Clinical subtype"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377796"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Phosphoribosylpyrophosphate synthetase superactivity"}],"ORPHA":"3222","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_3222"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Severe phosphoribosylpyrophosphate (PRPP) synthetase superactivity is the severe and early-onset form of PRPP synthetase superactivity (see this term), an X-linked disorder of purine metabolism associated with hyperuricemia and hyperuricosuria, that is characterized by urolithiasis, gout and neurodevelopmental anomalies."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"300661","DisorderMappingRelation":[{"id":"21534","Name":[{"lang":"en","label":"NTBT (narrower term maps to a broader term)"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]},{"Name":[{"lang":"en","label":"Infancy"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"X-linked recessive"}]}]}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"Severe PRPP synthetase superactivity"},{"lang":"en","label":"Severe PRPS1 superactivity"}]}]}]}